K231383

Substantially Equivalent

Terragene® Bionova® Self-Contained Biological Indicator (BT95), Terragene® Bionova® Self-Contained Biological Indicator (BT96), Terragene® Chemdye® Chemical Process Indicator (CD42), Terragene® Cintape® Chemical Process Indicator Tape (CT40)

Applicant: Terragene S.A.
Product code: FRC
Advisory panel: General Hospital
Date received: 2023-05-12
Decision date: 2024-09-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Alvear, AR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.